Volume 17, Number 5—May 2011
Dispatch
Multitarget Test for Emerging Lyme Disease and Anaplasmosis in a Serosurvey of Dogs, Maine, USA
Peter W. Rand
, Eleanor H. Lacombe, Susan P. Elias, Bruce K. Cahill, Charles B. Lubelczyk, and Robert P. Smith
, Eleanor H. Lacombe, Susan P. Elias, Bruce K. Cahill, Charles B. Lubelczyk, and Robert P. Smith
Table 2
Risk factors vs. canine seroprevalence of Anaplasma phagocytophilum and Borrelia burgdorferi, Maine, USA, 2007*
| Variable |
No. dogs |
Borrelia burgdorferi | Anaplasma phagocytophilum | |||||
|---|---|---|---|---|---|---|---|---|
| No. (%) positive |
OR (95% CI) |
p value† |
No. (%) positive |
OR (95% CI) |
p value† |
|||
| Lyme vaccine | ||||||||
| Yes | 575 | 57 (9.9) | 49 (8.5) | |||||
| No |
483 |
75 (15.3) |
1.5 (1.1–2.1) |
0.008 |
23 (4.8) |
0.6 (0.3–0.9) |
0.02 |
|
| Travel‡ | ||||||||
| All dogs | ||||||||
| None | 357 | 49 (13.7) | 27 (7.6) | |||||
| >1 |
730 |
89 (12.2) |
0.9 (0.6–1.3) |
NS |
50 (6.9) |
0.9 (0.6–1.5) |
NS |
|
| Unvaccinated dogs | ||||||||
| None | 163 | 21 (12.9) | 8 (4.9) | |||||
| >1 |
320 |
53 (16.6) |
1.3 (0.8–2.3) |
NS |
15 (4.7) |
0.9 (0.4–2.3) |
NS |
|
| Tick control products | ||||||||
| All dogs | ||||||||
| No | 182 | 20 (11.0) | 7 (3.9) | |||||
| Yes | 899 | 115 (12.9) | 1.2 (0.7–2.0) | NS | 66 (7.4) | 2.0 (0.9–4.4) | 0.08 | |
| Unvaccinated dogs | ||||||||
| No | 124 | 13 (10.5) | 3 (2.4) | |||||
| Yes |
350 |
59 (16.9) |
1.7 (0.9–3.3) |
0.09 |
18 (5.1) |
2.2 (0.6–7.6) |
NS |
|
| History of unexplained lameness | ||||||||
| No | 877 | 97 (11.1) | 42 (4.8) | |||||
| Yes | 191 | 40 (20.9) | 2.1 (1.4–3.2) | 0.0002 | 28 (15.2) | 3.6 (2.1–5.9) | <0.0001 | |
*A total of 1,087 dogs were tested. OR, odds ratio; CI, confidence interval; NS, not significant.
†Significance based on Pearson χ2 statistic with 1 degree of freedom.
‡Trips away from town of residence.
Page created: August 08, 2011
Page updated: August 08, 2011
Page reviewed: August 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.